Fingerprint
Dive into the research topics of 'Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinib'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically